Lenvima 18 mg

LENVIMA 18 MG capsules contain lenvatinib mesylate, a targeted therapy used in cancer treatment. This medication is designed to inhibit tumor growth and may be prescribed for specific types of cancer.

LENVIMA 18 MG capsules are primarily used in the treatment of certain types of cancer. Lenvatinib mesylate works by targeting specific proteins involved in tumor growth and blood vessel formation. This medication may be prescribed for conditions such as thyroid cancer or renal cell carcinoma, among others. Always consult a healthcare provider to determine if LENVIMA is suitable for your specific condition.

Common effects of LENVIMA 18 MG capsules may include fatigue, hypertension, diarrhea, and decreased appetite. Some individuals may experience more severe side effects, and it is important to monitor your health closely while taking this medication. Always report any unusual symptoms to your healthcare provider.

LENVIMA 18 MG capsules should be handled with care and stored as directed. This medication may interact with other drugs, so it is important to inform your healthcare provider about all medications you are taking. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

LENVIMA 18 MG capsules may interact with certain medications, including those that affect blood pressure or blood clotting. It is also important to avoid grapefruit and grapefruit juice, as they can affect how your body processes this medication. Always consult your healthcare provider before starting or stopping any medication while taking LENVIMA.